Full Length Research Paper
References
Adanu RG (2012). Personal communication. | ||||
Attoh S, Asmah R, Wiredu, EK, Gyasi R, Tettey Y (2010). Human Papilloma virus genotypes in Ghanaian women with cervical carcinoma, East Africa Med. J. 87(8):345-347. Pubmed |
||||
Ault KA, Giuliano AR, Edwards RP, Tamms G, Kim LL, Smith JF, Jansen KU, Allende M, Taddeo FJ, Skulsky D, Barr E (2004). Phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine. Vaccine 22 (23-24):3004-3007. Crossref |
||||
Bosch FX, de Sanjose S (2003). Human papilloma virus and cervical cancer-burden and assessment of causality. J. Natl. Cancer Inst. Monogr. 31:3-13. Crossref |
||||
Bosch FX, Qiao YL, Castellsagué X (2006). The epidemiology of human papillomavirus infection and its association with cervical cancer. Intl. J. Gynecol. Obst. 94:8-21. Crossref |
||||
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009). A review of human carcinogens-Part B: Biological Agents Lancet Oncol. 10:321-322. Crossref |
||||
Castle PE, Solomon D, Schiffman M, Wheeler CM (2005). Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J. Natl. Cancer Inst. 97(14):1066-1071. Crossref |
||||
Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F (2005). Carcinogenicity of human papillomaviruses. WHO International Agency for Research on Cancer. Lancet Oncol. 6(4):204. Crossref |
||||
Didelot-Rousseau MN, Nagot N, Costes-Martineau V, Vallès X, Ouedraogo A, Konate I, Weiss HA, Van de Perre P, Mayaud P, Segondy M (2006). Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br. J. Cancer 7:95(3):355-362. | ||||
Erickson BK, Alvarez, RD, Huh WK (2013). Human Papillomarvirus: What Every Provider Should Know. Am. J. Obst. Gynecol. 14:1-7. | ||||
Ghana Health Service (GHS) (2013). Ministry of Health Press release, Ghana. | ||||
Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU; (2002). Proof of Principle Study Investigators. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347(21):1645-1651. Crossref |
||||
Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ (1992). Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79(3):328-337. Crossref |
||||
Mu-oz N, Bosch X, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJF, Meijer CJL (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527. Crossref |
||||
Mu-oz N, Méndez F, Posso H, Molano M, van den Brule AJ, Ronderos M, Meijer C, Mu-oz A, Instituto Nacional de Cancerologia HPV Study Group (2004). Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J. Infect. Dis. 190(12):2077-2087. Crossref |
||||
Parkin DM, Pisani P, Ferlay J (1999). Global cancer statistics. CA Cancer J. Clin. 49(1):33-64. Crossref |
||||
Schiffman M, Castle PE (2005). The promise of global cervical-cancer prevention. N. Engl. J. Med. 353:2101-2104. Crossref |
||||
Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Wright TC, Solomon D, Chen Z, Schussler J, Castle PE, Burk RD (2005). The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337(1):76-84. Crossref |
||||
Schiffman M, Kruger-Kjær S (2003). Natural history of anogenital human papillomavirus infection and neoplasia. J. Natl. Cancer Inst. Monogr. 31:14-19. Crossref |
||||
Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Franco EL (2003). Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 95(17):1336-1343. Crossref |
||||
Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallweiner D, Kandolf R, Bultmann B (2004). Detection and typing of human papillomavirus by E6 nested multiplex PCR. J. Clin. Micobiol. 42:3176-3184. Crossref |
||||
Trottier H, Mahmud S, Duarte-Franco E, Villa LL, Costa MC, Sobrinho JP Rohan TE, Ferenczy A, Franco EL (2006). Human Papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol. Biomarkers Prev. 15(7):1274-1280. Crossref |
||||
Valles X, Murga GB, Hernandez G, Sabid M, Chuy A, Alameda F, San Jose S-D, Bosch FX, Pedrosa I, Castelle S, Casabona J (2009). High prevalence of human papillomavirus infection in the female population of Guatemala. Int. J. Cancer 125:1161-1167. Crossref |
||||
Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson S-E, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Stoler MH, Ferenczy A, Harper DM, Tamms GM (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efï¬cacy trial. Lancet Oncol. 6(5):271-278. Crossref |
||||
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Mu-oz N (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189(1):12-19. Crossref |
||||
Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE (2009). Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J. Natl. Cancer Inst. 101(7):475-487. Crossref |
||||
Zur Hausen H (2000). Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92(9):690-698. Crossref |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0